Physician profile
David E Burday
NPI 1679594402
$6,241.33
in general payments reported to CMS, 2019-2025
39 companies · $1,367 in 2025
The $1,367 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,364 · 2020: $503 · 2021: $448 · 2022: $722 · 2023: $896 · 2024: $941 · 2025: $1,367.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,186 · Education: $18.55.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,186.22 |
| Education | $18.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $780.02 | 2019-2025 | |
| Astellas Pharma US INC | $629.87 | 2019-2025 | Xtandi, Veozah, Myrbetriq |
| Axonics, INC. | $600.54 | 2022-2024 | Axonics, Bulkamid |
| Abbvie INC. | $524.64 | 2019-2025 | Botox |
| Allergan, INC. | $509.18 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $376.41 | 2019-2025 | Adstiladrin |
| Boston Scientific Corporation | $360.20 | 2020-2025 | Axonics, Spaceoar Vue System - 10ml, Ams 700 |
| Amgen INC. | $283.23 | 2019-2024 | Prolia |
| Janssen Biotech, INC. | $235.13 | 2019-2025 | Erleada, Akeega |
| Dendreon Pharmaceuticals LLC | $202.58 | 2019-2025 | Provenge |
| Bayer Healthcare Pharmaceuticals INC. | $156.68 | 2021-2025 | |
| Neotract INC. | $144.29 | 2019 | |
| Endo Pharmaceuticals INC. | $139.58 | 2019-2024 | Xiaflex, Edex, Aveed |
| Verity Pharmaceuticals INC. | $118.01 | 2022-2025 | Trelstar |
| Telix Pharmaceuticals | $115.38 | 2025 | Illuccix |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $110.05 | 2023-2025 | Gemtesa, Orgovyx |
| Urogen Pharma, INC. | $96.01 | 2023-2025 | Jelmyto |
| Myriad Genetic Laboratories, INC. | $83.35 | 2023-2025 | Prolaris |
| Tolmar, INC. | $80.01 | 2024-2025 | Eligard, Jatenzo |
| Medtronic, INC. | $68.71 | 2022-2023 | Interstim |
| Novartis Pharmaceuticals Corporation | $64.34 | 2024-2025 | |
| Antares Pharma, INC. | $58.66 | 2019-2021 | |
| Cook Medical LLC | $50.22 | 2021-2024 | Cook, Resonance |
| Olympus America INC. | $47.69 | 2023-2025 | Itind System |
| Karl Storz Endoscopy-America | $46.83 | 2021 | |
| Tempus Ai, INC | $40.53 | 2024 | Xt Cdx |
| Lsi Solutions INC | $39.90 | 2024 | Jnw Urtrac |
| Procept Biorobotics Corporation | $34.91 | 2025 | |
| Bioprotect Medical, INC. | $31.04 | 2025 | Bioprotect Balloon Implant System |
| Coloplast Corp | $31.01 | 2022 | |
| Blue Earth Diagnostics | $28.07 | 2023 | |
| Caris Mpi, INC. | $26.74 | 2025 | Mi Cancer Seek |
| Immunitybio, INC. | $24.88 | 2024 | |
| Endo USA, INC. | $24.08 | 2025 | Xiaflex, Aveed |
| Travere Therapeutics, INC. | $18.55 | 2025 | Thiola |
| Astrazeneca Pharmaceuticals Lp | $17.82 | 2021 | |
| Urovant Sciences INC | $14.52 | 2022 | |
| Laborie Medical Technologies Corp. | $14.28 | 2024 | Eclipse |
| Myovant Sciences INC. | $13.39 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Burday listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.